title: Effect on symptom control of structured information given to patients receiving chemotherapy.
abstract: OBJECTIVE
  The performance of a planned education model in patients receiving chemotherapy can alleviate the side effects of chemotherapy and thus can increase the quality of the patients' lives. In accordance with this view, this study was conducted with the purpose of examining the effect of planned education given to patients receiving chemotherapy on their symptom control.
  
  
  METHODS
  The study was quasi-experimental. A sample of 120 patients participated, of which 60 were in the experimental group (EG) and 60 were in the control group (CG). A patient data form and the chemotherapy symptom assessment scale (C-SAS) were used in order to collect the data. Median, Mann-Whitney U test and Wilcoxon signed rank test were used to analyze the data.
  
  
  RESULTS
  There were statistically significant decreases in the frequencies of the following symptoms: nausea, vomiting, constipation, pain, infectious signs, problems of mouth and throat, problems of skin and nails, appetite changes, weight loss or weight gain, feeling distressed/anxious, feeling pessimistic and unhappy, unusual fatigue, difficulty sleeping. Also, there were statistically significant decreases in the severity of eleven symptoms and on the discomfort levels of nine symptoms.
  
  
  CONCLUSIONS
  In the study, the planned education provided by the health-care providers had a positive effect on the symptom control of patients receiving chemotherapy.
authors.affiliation: Cumhuriyet University, Health Sciences Faculty, 58140 Sivas, Turkey. Electronic address: mukaddermollaoglu@hotmail.com.
authors.forename: Mukadder
authors.initials: M
authors.lastname: Mollaoğlu
authors.affiliation: Erciyes University, Mehmet Kemal Dedeman Oncology Hospital, Hematology-Oncology Unit, Erciyes, Turkey.
authors.forename: Gülyeter
authors.initials: G
authors.lastname: Erdoğan
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016022:Case-Control Studies; D064420:Drug-Related Side Effects and Adverse Reactions / Q000209:etiology* / Q000503:physiopathology; D005221:Fatigue / Q000139:chemically induced / Q000453:epidemiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced / Q000453:epidemiology; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D010146:Pain / Q000139:chemically induced / Q000453:epidemiology; D010353:Patient Education as Topic / Q000379:methods*; D011788:Quality of Life; D018570:Risk Assessment; D012720:Severity of Illness Index; D012737:Sex Factors; D063189:Symptom Assessment; D014839:Vomiting / Q000139:chemically induced / Q000453:epidemiology; D015431:Weight Loss; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents
keywords: C-SAS; Cancer; Chemotherapy; Patient education; Symptom assessment